However, our findings are consistent with the prospect of sPLA2-IIa being a ‘chicken’ rather than just another ‘egg’ with respect to cardiovascular disease, very much in contrast to C-reactive protein [28]. This evidence concerns the gene CRP and cardiovascular disorder.